$44.52▼-1.30 (-2.84%)
Extended:$45.82+1.30 (+2.92%)· 10:23 PM ET
Chugai Pharmaceutical Co., Ltd. (CHGCF)
R&D Expenses
¥191.90B
TTM · Period ending: · JPY

CHGCF R&D Expenses
Latest reported¥191.90B JPYperiod ending
Latest reported¥191.90B JPYperiod ending
CHGCF R&D Expenses · JPY (¥0.00 → ¥191.90B)
Annual R&D Expenses
High-resolution chart · PNG
What is r&d expenses?
Research and development spending.
CHGCF r&d expenses history
Annual fiscal periods · JPY. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (JPY) |
|---|---|
| 187,761,700,000 | |
| 181,440,000,000 | |
| 174,868,000,000 | |
| 149,626,000,000 | |
| 137,299,000,000 | |
| 117,850,000,000 | |
| 107,942,000,000 | |
| 99,202,000,000 | |
| 92,947,000,000 | |
| 85,011,000,000 | |
| 83,799,000,000 | |
| 80,800,000,000 | |
| 74,280,000,000 | |
| 55,107,000,000 | |
| 55,856,000,000 | |
| 54,702,000,000 | |
| 55,315,000,000 | |
| 53,225,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |
Explore More
CHGCF Financial Metrics
Explore 130+ historical metrics & ratios
Stock Comparison
Compare equities side by side
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance